
About Medvolt
Medvolt is a Technology company based in Pune (India) founded in 2021 by Madhura Vipra and Ritvik Vipra. An AI platform is developed for drug discovery and repurposing. It operates in the Technology and Healthcare sectors. Medvolt has raised $250 thousand across 2 funding rounds from investors including Kuhu Mohapatra. The company has 1 employees. Its chief executive, as recorded, is Madhura Vipra. Medvolt offers products and services including MedGraph - Topaaz, MedGraph - Rubie, MedGraph EDGE, and Peptide Therapeutics. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity in India is Medvolt Tech Private Limited (U72200PN2020PTC195544).
Company details
Medvolt was founded in 2021 in Pune, India, within the biotechnology sector. An AI platform is provided for drug discovery and repurposing, featuring modules for small and large molecule development as well as peptide therapeutics. Knowledge curation services are offered, alongside extraction of insights from various data sources to support pharmaceutical research and innovation.
- Headquarters Pune, India
- Employees 1
- Founders Madhura Vipra, Ritvik Vipra
- SectorsTechnologyHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website medvolt.ai
- Social LinkedIn X
- Legal Name Medvolt Tech Private Limited
- Date of Incorporation 30 Oct, 2020
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹53,114
FY 2025 · +13179% YoY
- Net Loss-₹27.4 Lakh
FY 2025 · -5159% margin
- EBITDA-₹27.2 Lakh
FY 2025 · -5119% margin
- Total Equity Funding$250K (USD)
in 2 rounds
- Latest Funding Round$250K (USD), Seed
Nov 2025
- Employee Count1
Associated legal entities of Medvolt
Medvolt operates through Medvolt Tech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medvolt Tech Private Limited CIN U72200PN2020PTC195544 | Active | 30 Oct 2020 | Pune, Maharashtra | ₹0.0 Cr | 2 | View details |
Products & Services of Medvolt
Medvolt offers a comprehensive portfolio of products and services, including MedGraph - Topaaz, MedGraph - Rubie, MedGraph EDGE, and Peptide Therapeutics.
AI and physics-based tool for developing novel chemical entities with toxicology checks.
Platform for repositioning drugs and identifying therapeutic targets efficiently.
Extracts insights from data sources for evidence-based drug discovery predictions.
Identifies optimal peptides for therapeutic use through in-silico modeling.
Funding Insights of Medvolt
Medvolt has successfully raised a total of $250K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250,000
- Total Rounds 2
- Last Round Seed β $250,000
- Investors Count 1
All 2 funding rounds of Medvolt with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $250,000 | Seed | β | β | β |
| Aug 2024 | Angel Round | β | β |
1 investors in total: 0 institutional and 1 angel.
Investors in Medvolt
Medvolt has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Kuhu Mohapatra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
KM Kuhu Mohapatra | Angel investor, ex-IBM, focused on tech startups in India | unknown_7efeb07c79f3445e9 |
Investor details for Medvolt
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Medvolt Tech Private Limited (Medvolt)
Medvolt Tech Private Limited is the primary company behind Medvolt. The board of Medvolt Tech Private Limited currently have 2 directors; the longest-serving is Madhura Ravindra Vipra, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhura Ravindra Vipra DIN 06612394 | Director | 30 Oct 2020 | 6 yrs | Medvolt Tech Private Limited |
| Ritvik Ravindra Vipra DIN 08942937 | Director | 30 Oct 2020 | 6 yrs | Medvolt Tech Private Limited |
People of Medvolt
2 people are tracked at Medvolt (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Medvolt
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Medvolt
Figures of Medvolt Tech Private Limited, the primary company behind Medvolt, for FY 2025. Revenue was ₹53,114 (+13179% year on year). Net loss was -₹27.4 Lakh (-5159% margin). EBITDA was -₹27.2 Lakh (-5119% margin). Revenue has grown at a compounded annual rate of -19% over three years.
- ₹53,114Revenue · FY 2025 · +13179% YoY
- -₹27.4 LakhNet loss · -5159% margin
- -₹27.2 LakhEBITDA · -5119% margin
- ₹1 LakhPaid-up capital
- -19%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Medvolt Tech Private Limited are on its company page.
Detailed financial statements for Medvolt
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Medvolt
3 dated milestones of Medvolt across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Medvolt is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $250K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medvolt
Medvolt was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Medvolt is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Madhura Vipra is the CEO of Medvolt, as recorded in our data. They have also founded this company.
Medvolt is a funded company, having raised a total of $250K across 2 funding rounds to date.
Medvolt has 1 employees.
The primary company behind Medvolt, Medvolt Tech Private Limited, reported revenue of βΉ53,114 for FY 2025, up 13179% year on year.
Medvolt was founded in 2021 in Pune, India, within the biotechnology sector. An AI platform is provided for drug discovery and repurposing, featuring modules for small and large molecule development as well as peptide therapeutics. Knowledge curation services are offered, alongside extraction of insights from various data sources to support pharmaceutical research and innovation.
Medvolt offers MedGraph - Topaaz, MedGraph - Rubie, MedGraph EDGE, and Peptide Therapeutics.
Medvolt has 1 investor. Key investors include Kuhu Mohapatra.
Medvolt operates through Medvolt Tech Private Limited.
The legal entities of Medvolt currently have 2 directors, including Madhura Ravindra Vipra, Ritvik Ravindra Vipra.